Transplantation risks and the real world: What does 'high risk' really mean?

American Journal of Transplantation

Volumn 9, Issue 1, 2009, Pages 23-30

  Freeman, R B ^a   Cohen, J T ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

Donor risk; Risk comparison; Waiting list

Indexed keywords

ADOLESCENT; ADULT; AGED; CHAGAS DISEASE; CHILD; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE TRANSMISSION; DONOR SELECTION; EPSTEIN BARR VIRUS; GRAFT FAILURE; GRAFT SURVIVAL; HEALTH CARE POLICY; HEART GRAFT; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HIGH RISK PATIENT; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T CELL LEUKEMIA VIRUS; KIDNEY GRAFT; LIVER GRAFT; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; MEDICAL DECISION MAKING; MORTALITY; ORGAN DONOR; PRESCHOOL CHILD; PRIORITY JOURNAL; RABIES; RISK ASSESSMENT; SCHOOL CHILD; SHORT SURVEY; TRANSPLANTATION;

ADOLESCENT; ADULT; CHILD; DECISION MAKING; DISEASE TRANSMISSION, INFECTIOUS; HUMANS; INFORMED CONSENT; MIDDLE AGED; RISK ASSESSMENT; TISSUE DONORS; TRANSPLANTATION; WAITING LISTS;

EID: 58049215504     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2008.02476.x     Document Type: Short Survey

References (32)

1. Childers MA, Hartman K. Four organ recipients infected with HIV. CBS Channel 2, Chicago. 11-13-2007. Available from : http://cbs2chicago.com/local/ hiv.organ.transplant.2.566288.html. Accessed October 19, 2008.
2. Paddock C. HIV from organ donor infects Chicago transplant patients. Medical News Today, November 14, 2007. Available from : http://www. medicalnewstoday.com/articles/88666.php. Accessed October 19, 2008.
3. Steenhuysen J. U.S. regulators join HIV transplant probe. Reuters. November 16, 2007. Available from : http://www.reuters.com/article/ middleeastCrisis/idUSN16603810. Accessed October 19, 2008.
4. Rogers M, Simonds R, Lawton K. Moseley R. Guidelines for preventing transmission of human immunodeficiency virus through transplantation of human tissue and organs. Morbidity and Mortality Weekly Report (CDC) 1994 43 : 1 17.
5. Grady D. Four transplant recipients contract H.I.V. New York Times. November 14, 2007. Available from : http://www.nytimes.com/2607/11/13/health/ 13cnd-organ.html. Accessed October 19, 2008.
6. Chicago Transplant Recipients Contract HIV From Organ Donor. eMaxHealth. 2007. Available from : http://www.emaxhealth.com/55/18103.html. Accessed: May 6, 2008.
7. Organ Procurement and Transplantation Network. OPTN/UNOS executive committee - proposal to require transplant centers to inform potential recipients about known high risk donor behavior. OPTN Website. 2008. Available from : http://www.optn.org/PublicComment/pubcommentPropSub_220.pdf. Accessed October 19, 2008.
8. United Network for Organ Sharing. Minimum procurement standards for an organ procurement organization (OPO). UNOS Website - Policies. Section 2. 2-21-2008. Available from : http://www.unos.org/policiesandbylaws/policies.asp? resources=true. Accessed October 19, 2008.
9. Freeman RB, Giatras I, Falagas ME et al. Outcome of transplantation of organs procured from bacteremic donors. Transplantation 1999 68 : 1107 1111.
10. Naimark D, Krahn MD, Naglie G, Redelmeier DA, Detsky AS. Primer on medical decision analysis: Part 5-Working with Markov processes. Med Decis Making 1997 17 : 152 159.
11. Birkmeyer JD, Liu JY. Decision analysis models: Opening the black box. Surgery 2003 133 : 1 4.
12. Stock PG. Kidney allocation policy development. United Network for Organ Sharing. November 6, 2007. Available from : http://www.optn.org/ SharedContentDocuments/KidneyAllocationPolicyDevelopmentUpdate - Q42007.pdf.
13. Feng S, Goodrich NP, Bragg-Gresham JL et al. Characteristics associated with liver graft failure: The concept of a donor risk index. Am J Transplant 2006 6 : 783 790.
14. Merion RM, Ashby VB, Wolfe RA et al. Deceased-donor characteristics and the survival benefit of kidney transplantation. JAMA 2005 294 : 2726 2733.
15. Bia MJ, Ramos EL, Danovitch GM et al. Evaluation of living renal donors. The current practice of US transplant centers. Transplantation 1995 60 : 322 327.
16. Ellison MD, McBride MA, Taranto SE, Delmonico Fl, Kauffman HM. Living kidney donors in need of kidney transplants: A report from the organ procurement and transplantation network. Transplantation 2002 74 : 1349 1351.
17. Trotter JF, Adam R, Lo CM, Kenison J. Documented deaths of hepatic lobe donors for living donor liver transplantation. Liver Transpl 2006 12 : 1485 1488.
18. Cohen JT, Neumann PJ. What's more dangerous, your aspirin or your car? Thinking rationally about drug risks (and benefits). Health Aff (Millwood) 2007 26 : 636 646.
19. Covello VT, Sandman PM, Slovic P. Risk Communication, Risk Statistics, and Risk Comparisons: A Manual for Plant Managers. Washington, DC : Chemical Manufacturers Association, 1988.
20. Trotter JF, Osgood MJ. MELD scores of liver transplant recipients according to size of waiting list: Impact of organ allocation and patient outcomes. JAMA 2004 291 : 1871 1874.
21. Slovic P. Perception of risk. Science 1987 236 : 280 285.
22. Shea KJ, Sopko NA, Ludrosky K et al. The effect of a donor's history of active substance on outcomes following orthotopic heart transplantation. Eur J Cardiothorac Surg 2007 31 : 452 456.
23. Halpern SD, Shaked A, Hasz RD, Caplan AL. Informing candidates for solid-organ transplantation about donor risk factors. N Engl J Med 2008 358 : 2832 2837.
24. Schweitzer EJ, Perencevich EN, Philosophe B, Bartlett ST. Estimated benefits of transplantation of kidneys from donors at increased risk for HIV or hepatitis C infection. Am J Transplant 2007 7 : 1515 1525.
25. Health Resources and Services Administration.Healthcare Systems Bureau. Division of Transplantation. US Department of Health and Human Services. 2007 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1997-2006. Rockville, MD, 2007.
26. Paya C, Humar A, Dominguez E et al. Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant 2004 4 : 611 620.
27. Slifkin M, Ruthazer R, Freeman R et al. Impact of cytomegalovirus prophylaxis on rejection following orthotopic liver transplantation. Liver Transpl 2005 11 : 1597 1602.
28. Fishman JA. Infection in solid-organ transplant recipients. N Engl J Med 2007 357 : 2601 2614.
29. Funch DP, Brady J, Ko HH, Dreyer NA, Walker AM. Methods and objectives of a large US multicenter case-control study of post-transplant lymphoproliferative disorder in renal transplant patients. Recent Results Cancer Res 2002 159 : 81 88.
30. Zou S, Dodd RY, Stramer SL, Strong DM. Probability of viremia with HBV, HCV, HIV, and HTLV among tissue donors in the United States. N Engl J Med 2004 351 : 751 759.
31. Fischer SA, Graham MB, Kuehnert MJ et al. Transmission of lymphocytic choriomeningitis virus by organ transplantation. N Engl J Med 2006 354 : 2235 2249.
32. Kauffman HM, McBride MA, Delmonico FL. First report of the United Network for Organ Sharing Transplant Tumor Registry: Donors with a history of cancer. Transplantation 2000 70 : 1747 1751.